Open

Testing whether blood and urine can be used to detect ctHPVDNA in women with known history of cervical cancer

To see whether a blood and urine test can be used to detect circulating tumor HPV DNA in women with cervical cancer. The hope is to be able to use this test in the future to help find cervical cancer earlier and detect any new cancer in people previously treatment for it.

Age & Gender

18 years ~ 99 years
Female, Focus on recruitment of transgender men

Location

North Carolina (Statewide)

What will be asked of you

The study involves the collection of research urine and blood samples as well as access to tissue samples (ex. biopsy) that were collected per standard of care.

Total length of participation:
Participants will be followed for five years, until withdrawal from study, or death, whichever occurs first.

Looking for Specific Volunteers

Able to participate:

New medical diagnoses of cervical cancer
Must be willing to comply with study procedures based on the judgement of the investigator or protocol designee

Not eligible if:

Pregnant women

Contact the Team

Visit Location

Lineberger Clinical Research

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Shivani Sud
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Cervical)
Women's Health

IRB Number

20-3143

ClinicalTrials.gov

NCT04743674

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.